These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26464129)

  • 1. Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes.
    Chemaitilly W; Merchant TE; Li Z; Barnes N; Armstrong GT; Ness KK; Pui CH; Kun LE; Robison LL; Hudson MM; Sklar CA; Gajjar A
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):361-71. PubMed ID: 26464129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes.
    van Iersel L; Li Z; Srivastava DK; Brinkman TM; Bjornard KL; Wilson CL; Green DM; Merchant TE; Pui CH; Howell RM; Smith SA; Armstrong GT; Hudson MM; Robison LL; Ness KK; Gajjar A; Krull KR; Sklar CA; van Santen HM; Chemaitilly W
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6101-6115. PubMed ID: 31373627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of 493 consecutive girls with idiopathic central precocious puberty: a single-center study.
    Giabicani E; Allali S; Durand A; Sommet J; Couto-Silva AC; Brauner R
    PLoS One; 2013; 8(7):e70931. PubMed ID: 23936254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system imaging in girls with central precocious puberty: when is necessary?
    Vuralli D; Gonc EN; Alikasifoglu A; Kandemir N; Ozon ZA
    Arch Endocrinol Metab; 2021 May; 64(5):591-596. PubMed ID: 34033300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F; Federico G; Harrell JC; Saggese G
    Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for organic central precocious puberty and utility of simplified gonadotropin-releasing hormone tests.
    Choi JH; Shin YL; Yoo HW
    Pediatr Int; 2007 Dec; 49(6):806-10. PubMed ID: 18045276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C; Couto-Silva AC; Sainte-Rose C; Chemaitilly W; Kalifa C; Doz F; Zerah M; Brauner R
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes of Patients with Central Precocious Puberty due to Hypothalamic Hamartoma after GnRHa Treatment: Anthropometric, Metabolic, and Reproductive Aspects.
    Ramos CO; Latronico AC; Cukier P; Macedo DB; Bessa DS; Cunha-Silva M; Arnhold IJ; Mendonca BB; Brito VN
    Neuroendocrinology; 2018; 106(3):203-210. PubMed ID: 28558376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand.
    Jaruratanasirikul S; Thaiwong M
    J Pediatr Endocrinol Metab; 2011; 24(7-8):519-23. PubMed ID: 21932591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life.
    Bizzarri C; Spadoni GL; Bottaro G; Montanari G; Giannone G; Cappa M; Cianfarani S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):433-9. PubMed ID: 24297793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of precocious puberty in girls during the COVID-19 pandemic: a pilot study.
    Sun H; Qian Y; Wan N; Liu L
    BMC Pediatr; 2023 Apr; 23(1):185. PubMed ID: 37081435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models for predicting the adult height and age at first menstruation of girls with idiopathic central precocious puberty.
    Giabicani E; Lemaire P; Brauner R
    PLoS One; 2015; 10(3):e0120588. PubMed ID: 25837693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Patients with Central Precocious Puberty Due to Loss-of-Function Mutations in the MKRN3 Gene after Treatment with Gonadotropin-Releasing Hormone Analog.
    Ramos CO; Macedo DB; Canton APM; Cunha-Silva M; Antonini SRR; Stecchini MF; Seraphim CE; Rodrigues T; Mendonca BB; Latronico AC; Brito VN
    Neuroendocrinology; 2020; 110(7-8):705-713. PubMed ID: 31671431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.
    Palmert MR; Mansfield MJ; Crowley WF; Crigler JF; Crawford JD; Boepple PA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4480-8. PubMed ID: 10599706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precocious puberty in children with tumours of the suprasellar and pineal areas: organic central precocious puberty.
    Rivarola ; Belgorosky A; Mendilaharzu H; Vidal G
    Acta Paediatr; 2001 Jul; 90(7):751-6. PubMed ID: 11519977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone.
    Vottero A; Pedori S; Verna M; Pagano B; Cappa M; Loche S; Bernasconi S; Ghizzoni L
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1284-7. PubMed ID: 16449342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological and Incidental Findings in 403 Taiwanese Girls With Central Precocious Puberty at Initial Diagnosis.
    Chiu CF; Wang CJ; Chen YP; Lo FS
    Front Endocrinol (Lausanne); 2020; 11():256. PubMed ID: 32431668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.